The Septin9 Test Allows You to Offer a Convenient and Reliable Alternative for Colorectal Cancer Early Detection to Your Patients.
The Septin9 blood test permits simple and reliable detection of the biomarker
mSEPT9 in blood plasma.
This biomarker is specific for colorectal cancer.
The methylated gene SEPT9 is found in colorectal cancer but not in the healthy colon. This so-called epigenetic modification can be detected by the Septin9 test in a blood draw.
In October 2009, the Septin9 test was approved as a CE-marked test in Europe.
